Best of the Year AI in healthcare AI Tool

Cruxi is an AI-powered regulatory platform designed to streamline medical device submissions to the FDA and global authorities. It automates workflows for 510(k), De Novo, PMA, and more, significantly reducing preparation time and preventing common rejection issues.

Tempus is a leading technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. It leverages one of the world's largest libraries of multimodal clinical and molecular data to help physicians deliver personalized patient care and accelerate the discovery and development of new therapeutics.

1910genetics is a biotechnology company revolutionizing drug discovery with its multimodal AI platform, ITO™. Powered by lab automation, it accelerates the design of both small and large molecule therapeutics, aiming to make previously undruggable targets treatable for diseases like cancer, and neurological or autoimmune disorders.

Verge Genomics is a biotechnology company leveraging an all-in-human, AI-powered platform, CONVERGE®, to discover and develop drugs for complex diseases. By analyzing vast human genomic datasets, it aims to accelerate the creation of effective treatments for conditions like ALS, Parkinson's, and Frontotemporal Dementia, moving from discovery to clinic significantly faster than traditional methods.

RSIP Vision is a world-class leader in providing custom AI and computer vision R&D solutions for medical imaging. With over 25 years of experience, they partner with medical device companies to develop innovative, clinically-proven software for diagnostics, surgical guidance, and image analysis across various medical fields.

Unlearn is an AI-powered platform that accelerates clinical trials by creating 'Digital Twins' of patients. By leveraging machine learning models trained on vast historical data, it generates prognostic forecasts for each trial participant. This allows pharmaceutical and biotech companies to design smaller, faster, and more powerful studies, optimize trial design, and make more informed decisions, ultimately fast-tracking the development of new therapies.